http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10511346-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L7-152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L2-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-10
filingDate 1995-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1998-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H10511346-A
titleOfInvention Chalcone and esters thereof with antiproliferative activity in uterus, ovary and breast tumors
abstract (57) [Summary]nThe present invention relates to a number of natural or synthetic chalcones and saturated and unsaturated linear or branched fatty acids containing up to 22 carbon atoms in the treatment and prevention of uterine, ovarian and breast tumors. It relates to the use of esters, as well as the formulations containing them. Chalcones such as isocordoin, cordoin, 2-hydroxyderricin, 2 ', 4'-dihydroxychalcone, 4,2', 4'-trihydroxychalcone have marked affinity for the type II estrogen receptor as well as uterus, ovary , And has antiproliferative activity against breast tumor cell lines. These molecules have been found to be useful in both treating and preventing such tumors.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004096198-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7498357-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009536655-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005054170-A1
priorityDate 1994-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448537
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426107687
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6438503
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426268527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414862906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID452110
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426095828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5376979
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521634
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426321645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6990
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546720
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426321162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482810
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408497310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427875815
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5879763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485496
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67766433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9974390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426084085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5961410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42607665
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10065724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280343
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588

Total number of triples: 91.